MedicalMinute Series

Share

Program Content

Activities

  • Starting ICI Therapy
    MedicalMinute: What to Expect When Your Patient Is Starting Immune Checkpoint Inhibitor–Based Therapy
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 23, 2021

    Expires: March 22, 2022

  • Common irAEs
    MedicalMinute: A Practical Guide to Managing Common Immune-Related Adverse Events
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 23, 2021

    Expires: March 22, 2022

  • Less Common irAEs
    MedicalMinute: A Practical Guide to Managing Less Common Immune-Related Adverse Events
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 23, 2021

    Expires: March 22, 2022

  • ICIs & COVID-19 Vaccines
    MedicalMinute: Emerging Guidance on COVID-19 Vaccination in Patients Receiving Immune Checkpoint Inhibitors
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 24, 2021

    Expires: May 23, 2022

Faculty

cover img faculity

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

cover img faculity

Jeffrey S. Weber, MD, PhD

Senior Member and Director
Comprehensive Melanoma Research Center
H. Lee Moffitt Cancer Center
Tampa, Florida

cover img faculity

Matthew Zibelman, MD

Assistant Professor
Hematology Oncology
Attending Physician
Genitourinary Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Merck Sharp & Dohme Corp.